CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,140,000 | +1400.0% | 88,892 | +568.6% | 0.10% | +1385.7% |
| Q2 2021 | $76,000 | -58.7% | 13,295 | -78.6% | 0.01% | -78.1% |
| Q3 2020 | $184,000 | +360.0% | 62,022 | +478.3% | 0.03% | +700.0% |
| Q4 2019 | $40,000 | -93.0% | 10,725 | -90.5% | 0.00% | -87.9% |
| Q1 2019 | $574,000 | +185.6% | 112,568 | +7.7% | 0.03% | +200.0% |
| Q4 2018 | $201,000 | +204.5% | 104,506 | +523.4% | 0.01% | +266.7% |
| Q4 2017 | $66,000 | -14.3% | 16,764 | -44.8% | 0.00% | -25.0% |
| Q3 2017 | $77,000 | – | 30,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |